How One Keto Trial Set Off a New War in the Nutrition World
1 min read
Summary
A new peer-reviewed journal paper on the potential benefits of the keto diet has divided the nutrition world and sparked debates on social media.
The study examines the effect of the high-fat, low-carb keto diet on cholesterol, and claims to show that the diet does not increase the risk of atherosclerosis (fatty deposits in arteries).
The study’s critics say it is based on flawed methodology, and point to the fact that its conclusion is at odds with much existing research.
It has also been criticized for allegedly moving the goalposts during its research.
One of the study’s authors, Dave Feldman, a self-styled “citizen scientist” who has no medical qualifications, has faced criticism for allegedly putting his own desired outcomes ahead of scientific rigor.
Feldman claims the study found no association between LDL cholesterol and plaque in the patients, and no association between apolipoprotein B (ApoB) and plaque.
The alleged findings run counter to large amounts of existing evidence.
Some are now calling for the paper to be retracted.
